Sabra Health Care REIT (SBRA) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
2 Feb, 2026Executive summary
Second quarter 2024 net income was $24.0 million, up from $21.2 million in Q2 2023, with FFO and normalized FFO at $0.35 per share, and AFFO and normalized AFFO at $0.36 per share.
SHOP (senior housing operating portfolio) cash NOI grew 17.7% year-over-year, with improved occupancy and margins in both senior housing and skilled nursing.
The company leverages industry experience, a resilient balance sheet, and ESG initiatives to deliver long-term value and support operator expansion.
Portfolio diversification and disciplined capital recycling remain key strategies amid labor, inflation, and regulatory challenges.
Financial highlights
Q2 2024 revenues were $176.1 million, up from $161.2 million in Q2 2023; FFO per share was $0.35 and AFFO per share was $0.36, both up $0.01 sequentially.
Year-over-year, normalized FFO and AFFO per share grew 6%.
SHOP same-store cash NOI grew 17.7% year-over-year and 9.9% sequentially; Canadian senior housing cash NOI rose 23.9% year-over-year.
Medicaid rate increases averaged 7% weighted, with a 4.2% Medicare market basket increase.
Net Debt to Adjusted EBITDA was 5.45x as of June 30, 2024.
Outlook and guidance
2024 full-year guidance (per diluted share): net income $0.48–$0.55, FFO $1.33–$1.36, normalized FFO $1.36–$1.39, AFFO $1.39–$1.42, normalized AFFO $1.41–$1.44.
Guidance assumes mid-to-high teens year-over-year same store cash NOI growth for managed senior housing.
Guidance incorporates all announced investment, disposition, and ATM equity program activity.
No additional investment, disposition, or capital transactions assumed beyond those disclosed.
Latest events from Sabra Health Care REIT
- Q4 2025 delivered strong managed senior housing growth and robust 2026 FFO/AFFO guidance.SBRA
Q4 202513 Feb 2026 - Q3 2024 saw strong earnings, raised guidance, and robust liquidity amid sector growth.SBRA
Q3 202417 Jan 2026 - 2024 saw strong AFFO growth and margins, with 2025 guidance projecting further FFO gains.SBRA
Q4 20248 Dec 2025 - Director elections, auditor ratification, and executive pay highlight strong governance and ESG.SBRA
Proxy Filing2 Dec 2025 - Annual meeting to vote on directors, executive pay, and auditor ratification, all board-backed.SBRA
Proxy Filing2 Dec 2025 - Q2 2025 saw higher earnings, strong senior housing growth, and raised 2025 guidance.SBRA
Q2 202523 Nov 2025 - Q1 2025 delivered higher earnings, strong FFO, and robust liquidity with major deals pending.SBRA
Q1 202519 Nov 2025 - Q3 2025 delivered strong managed senior housing growth, acquisitions, and a Moody's upgrade.SBRA
Q3 202513 Nov 2025